News
Recent milestones across the Huang Lab’s academic and translational work.
Jun 15, 2026
The Huang Lab published a review in Hematological Oncology on the biological barriers limiting CAR T cell therapy in solid tumors and the engineering strategies to overcome them.
Read articleJun 10, 2026
Vincent Pham was named a 2026 Future Texas Business Legend by the Texas Business Hall of Fame, receiving the Carlos & Malú Alvarez Award.
Read articleMay 12, 2026
Alejandra Lorenzen will present Huang Lab work on a synthetic blood oxygen carrier (OcVe) at the AIM 2026 Health R&D Summit, where Huang Lab members and Abioremedi will meet partners.
Read articleApr 24, 2026
Vincent Pham was recognized as a 2026 SynBioBeta Next-Gen BioLeader and is attending SynBioBeta to discuss what Powerhouse is building.
Read articleApr 16, 2026
Vincent Pham joined VelocityTX's Vital Signs podcast to talk cell therapy, liver cancer, and the Texas biotech ecosystem.
Read articleApr 2, 2026
Vincent Pham was named an AACR Early-Career Scholar and will present two cancer-associated cachexia studies at the 2026 Annual Meeting.
Read articleMar 3, 2026
Vincent Pham received the GSBS Spring 2026 Travel Award, providing $1,500 to support his presentation at the AACR Annual Meeting 2026.
Read articleMar 1, 2026
Alejandra Lorenzen and Dr. Gang Huang published a commentary in Blood Science on how driver mutations shape the stem cell landscape of essential thrombocythemia.
Read articleFeb 26, 2026
The Huang Lab published a JCI Insight study introducing a new Fanconi anemia mouse model and showing that an RNA polymerase inhibitor can rescue bone marrow failure.
Read articleFeb 25, 2026
The Huang Lab received support to advance preclinical development of PH102 for hepatocellular carcinoma, reinforcing the lab’s translational focus.
Read articleFeb 2, 2026
The Huang Lab published a JCI research letter showing that luspatercept improves anemia and reduces complications in the Townes mouse model of sickle cell disease.
Read articleOct 1, 2025
Vincent Pham will present Huang Lab research at the 2025 San Antonio Liver Cancer Symposium.
Read articleSep 10, 2025
Dr. Gang Huang will present the lab’s latest work on PH102 at the 2025 La Frontera Symposium.
Read articleAug 1, 2025
The lab published a new review linking mitophagy to cancer and neurodegenerative disease biology and future therapies.
Read articleJul 2, 2025
The lab received new support from the Owens Medical Research Foundation to advance ongoing research priorities.
Read articleJun 6, 2025
A collaborative multi-program grant will support work on mitophagy’s role in adipose tissue depletion during cancer-associated cachexia.
Read articleApr 2, 2025
Vincent Pham will present new preclinical findings from the Huang Lab at AACR 2025 in Chicago.
Read articleJan 9, 2025
A new Journal of Clinical Investigation paper defines an essential role for CPT1A in hematopoietic stem cell maintenance.
Read articleDec 1, 2024
The lab will present new findings in hematopoietic stem cell biology and therapeutic mechanisms at ASH 2024.
Read articleOct 9, 2024
Vincent Pham joined the inaugural cohort of the NCI T32 EDGe Training Program in Cancer.
Read articleOct 9, 2024
The Morrison Trust selected the Huang Lab for funding on mechanisms of tumor-derived lactate in cancer-associated cachexia.
Read articleSep 30, 2024
The lab will present new preclinical PH102 data at the 2024 San Antonio Liver Cancer Symposium.
Read articleSep 9, 2024
The lab published a review in Frontiers in Immunology on the immune imbalance underlying cytokine storm syndromes.
Read articleAug 4, 2024
Powerhouse Therapeutics was formed to advance PH102 and selected solid-tumor cell therapy programs toward the clinic.
Read article